• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

    5/29/24 8:07:38 AM ET
    $AAL
    $ASTI
    $AWIN
    $AZ
    Air Freight/Delivery Services
    Consumer Discretionary
    Semiconductors
    Technology
    Get the next $AAL alert in real time by email

    Shares of Ooma, Inc. (NYSE:OOMA) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and issued strong guidance for the second quarter.

    The company also issued FY25 adjusted EPS guidance above estimates.

    Ooma shares jumped 17% to $9.24 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • ReShape Lifesciences Inc. (NASDAQ:RSLS) rose 130.2% to $0.4789 in today's pre-market trading after the company announced that it received a notice of allowance for its U.S. patent application 17/572,387 titled “INTRAGASTRIC DEVICE (FOR TREATING OBESITY)”
    • Scorpius Holdings, Inc. (NYSE:SCPX) shares gained 48.7% to $0.1665 in pre-market trading after gaining 6% on Tuesday.
    • Banzai International, Inc. (NASDAQ:BNZI) gained 39.2% to $0.2440 in pre-market trading. Banzai, last week, announced the pricing of a $2.5 million public offering.
    • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) gained 33.6% to $0.1996 in pre-market trading following a 3% decline on Tuesday.
    • A2Z Smart Technologies Corp (NASDAQ:AZ) shares rose 21.4% to $0.51 in pre-market trading.
    • Cheche Group Inc. (NASDAQ:CCG) shares gained 18.1% to $1.57 in pre-market trading. Cheche Group is expected to host a conference call to discuss first quarter 2024 results on Thursday, May 30.
    • Digital Brands Group Inc (NASDAQ:DBGI) shares climbed 14.2% to $2.00 in pre-market trading. Digital Brands Group, last week, posted a first-quarter loss of 46 cents per share.
    • Mainz Biomed N.V. (NASDAQ:MYNZ) gained 13.4% to $0.8615 in pre-market trading after jumping over 34% on Tuesday.
    • Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) gained 9.6% to $22.00 in pre-market trading.

    Losers

    • Cue Health Inc. (NASDAQ:HLTH) shares declined 41.9% to $0.0526 in pre-market trading after the company announced that it filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business.
    • Sharps Technology, Inc. (NASDAQ:STSS) shares declined 35% to $0.3364 in pre-market trading after surging 141% on Tuesday. In an exchange filing, the company said it has entered into a series of agreements with Nephron SC and Nephron Sterile Compounding Centers.
    • SOBR Safe, Inc. (NASDAQ:SOBR) shares dipped 29.6% to $0.2991 in pre-market trading after jumping 84% on Monday.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares fell 29.5% to $6.44 in pre-market trading. AERWINS Technologies shares jumped 143% on Tuesday after the company reported a year-over-year increase in first-quarter EPS results.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares fell 25.5% to $0.8709 in pre-market trading. Faraday Future Intelligent Electric recently said it is withdrawing its production target guidance for 2024 due to current market conditions and current levels of funding.
    • Exicure, Inc. (NASDAQ:XCUR) shares fell 21.6% to $0.2897 in pre-market trading after gaining 9% on Tuesday.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) shares fell 17.5% to $0.3380 in pre-market trading. Innovative Eyewear shares dipped 58% on Tuesday after the company announced a $2.5 million registered direct offering.
    • Onfolio Holdings, Inc. (NASDAQ:ONFO) shares fell 15% to $1.13 in pre-market trading after jumping around 36% on Tuesday. Onfolio Holdings, last week, posted a quarterly loss of 14 cents per share.
    • Predictive Oncology Inc. (NASDAQ:POAI) fell 14.6% to $1.78 in pre-market trading. Predictive Oncology shares surged 31% on Tuesday after the company announced results from its ovarian caner study with UPMC Magee-Womens Hospital.
    • American Airlines Group Inc. (NASDAQ:AAL) shares declined 7.2% to $12.47 in pre-market trading after the company announced the departure of its executive vice president and lowered guidance for the second quarter.

    Now Read This: Advance Auto Parts, Ooma And 3 Stocks To Watch Heading Into Wednesday

    Get the next $AAL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAL
    $ASTI
    $AWIN
    $AZ

    CompanyDatePrice TargetRatingAnalyst
    American Airlines Group Inc.
    $AAL
    1/30/2026$19.00 → $17.00Buy
    TD Cowen
    American Airlines Group Inc.
    $AAL
    1/9/2026$20.00Neutral → Positive
    Susquehanna
    American Airlines Group Inc.
    $AAL
    12/18/2025$17.00Equal Weight
    Wells Fargo
    American Airlines Group Inc.
    $AAL
    12/12/2025Neutral → Buy
    UBS
    American Airlines Group Inc.
    $AAL
    12/9/2025$16.75Market Perform
    BMO Capital Markets
    American Airlines Group Inc.
    $AAL
    12/4/2025$19.00Buy
    Citigroup
    Syndax Pharmaceuticals Inc.
    $SNDX
    10/16/2025$40.00Buy
    H.C. Wainwright
    Syndax Pharmaceuticals Inc.
    $SNDX
    9/10/2025$44.00Buy
    Stifel
    More analyst ratings

    $AAL
    $ASTI
    $AWIN
    $AZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Donahue Kevin Michael bought $1,034,350 worth of shares (685,000 units at $1.51) (SEC Form 4)

    4/A - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/20/26 10:29:36 AM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Donahue Kevin Michael bought $258,827,700,000 worth of shares (643,850 units at $402,000.00) (SEC Form 4)

    4 - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/16/26 3:42:37 PM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $ASTI
    $AWIN
    $AZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on American Airlines with a new price target

    TD Cowen reiterated coverage of American Airlines with a rating of Buy and set a new price target of $17.00 from $19.00 previously

    1/30/26 6:46:33 AM ET
    $AAL
    Air Freight/Delivery Services
    Consumer Discretionary

    American Airlines upgraded by Susquehanna with a new price target

    Susquehanna upgraded American Airlines from Neutral to Positive and set a new price target of $20.00

    1/9/26 8:23:08 AM ET
    $AAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Wells Fargo initiated coverage on American Airlines with a new price target

    Wells Fargo initiated coverage of American Airlines with a rating of Equal Weight and set a new price target of $17.00

    12/18/25 9:07:24 AM ET
    $AAL
    Air Freight/Delivery Services
    Consumer Discretionary

    $AAL
    $ASTI
    $AWIN
    $AZ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AAL
    $ASTI
    $AWIN
    $AZ
    SEC Filings

    View All

    SEC Form S-8 filed by Syndax Pharmaceuticals Inc.

    S-8 - Syndax Pharmaceuticals Inc (0001395937) (Filer)

    2/26/26 4:27:12 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Syndax Pharmaceuticals Inc.

    10-K - Syndax Pharmaceuticals Inc (0001395937) (Filer)

    2/26/26 4:04:57 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Syndax Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer)

    2/26/26 4:02:29 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $ASTI
    $AWIN
    $AZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    – Total revenue of $68.7 million in 4Q25 and $172.4 million in FY2025 –  – Revuforj® (revumenib) net revenue of $44.2 million in 4Q25, a 38% increase vs 3Q25, and $124.8 million in FY2025 – – Niktimvo™ (axatilimab-csfr) net revenue of $56.0 million in 4Q25, a 22% increase vs 3Q25, and $151.6 million in FY2025, resulting in Syndax collaboration revenue of $42.4 million in FY2025 – – Completed enrollment in Phase 2 IPF trial of axatilimab; topline data expected in 4Q26 – – Company to host a conference call today at 4:30 p.m. ET – NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer ther

    2/26/26 4:01:00 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ooma AirDial Wins Two Gold Merit Awards for Security and Cloud Services

    Recognition Highlights Ooma AirDial's Leadership in Modernizing Critical Communications as Copper Networks Retire Ooma, Inc. (NYSE:OOMA), a provider of advanced communications services for businesses and consumers, today announced that Ooma AirDial® has earned two Gold Merit Awards in the 2026 Merit Awards for Telecom & Wireless program, receiving top honors in both the Security and Cloud Services categories. The Merit Awards are an independent, global awards program that recognizes innovation and leadership across enterprise technology markets. The program honors organizations and technologies that demonstrate excellence, innovation and measurable market impact. The dual Gold recogni

    2/26/26 6:01:00 AM ET
    $OOMA
    EDP Services
    Technology

    CORRECTED VERSION: Ascent Solar Technologies' PV Blankets to Power NOVI AI Geo-Intelligence Spacecraft, N1-ATLAS, Scheduled for Launch This Spring

    THORNTON, Colo., Feb. 25, 2026 (GLOBE NEWSWIRE) --  Ascent Solar Technologies ("Ascent" or the "Company") (NASDAQ:ASTI), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced that its previously delivered solar blankets have been successfully integrated into NOVI's N-1 ATLAS spacecraft, scheduled to fly on the upcoming SpaceX Falcon 9 Transporter-16 launch next month. NOVI's spring mission will demonstrate GENIE™ (Geospatial Ecosystem for Near Real-Time Information at the Edge), the company's flagship open-access, multi-sensor, edge-compute platform designed to provide low-cost, low-latency Earth observ

    2/25/26 4:39:35 PM ET
    $ASTI
    Semiconductors
    Technology

    $AAL
    $ASTI
    $AWIN
    $AZ
    Leadership Updates

    Live Leadership Updates

    View All

    UATP Appoints David Newington to Lead Asia-Pacific Commercial Team

    SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- UATP, the global network enabling organizations to simplify payment processes and expand their payment capabilities, announced today the appointment of David Newington as Managing Director, Commercial, Asia-Pacific, effective immediately. With more than 25 years of leadership experience spanning Payments, IT, and Corporate Travel, Newington brings a proven track record of driving growth, building high-performing teams, and delivering customer-centric solutions across Australia, the United States, and Singapore. In this role, Newington w

    12/17/25 8:00:00 AM ET
    $AAL
    $DAL
    $GOL
    Air Freight/Delivery Services
    Consumer Discretionary

    Niron Magnetics Expands Board of Directors with Seasoned Technology and Finance Experts to Lead the Next Chapter of Growth

    Jon Olson, current Board Member at AMD, Rocket Lab, and Kulicke & Soffa, and Eric Stang, CEO and Chairman of Ooma and current Board Member of Rambus, join Niron Magnetics' Board of Directors Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, announced the appointment of Jon Olson and Eric Stang to its Board of Directors. Their deep experience in technology, finance, and scaling high-growth public and private companies will help guide Niron Magnetics' journey as it expands manufacturing, commercial operations, and global partnerships in preparation for future growth. "Niron Magnetics is entering a pivotal moment. We're sca

    11/12/25 10:00:00 AM ET
    $AMD
    $KLIC
    $OOMA
    Semiconductors
    Technology
    EDP Services
    Military/Government/Technical

    Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy

    Appoints Shawn Matthews, CEO of DNA Holdings Venture, Inc., and Former CEO of Cantor Fitzgerald, to its Board of Directors Names Thomas McLaughlin and Sara Turken, JD, as Chief Investment Officer and General Counsel, respectively PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and the first Strategic Compute Reserve leveraging the Aethir ecosystem to democratize access to AI infrastructure, today announced additions to its leadership team and Board of Directors in support of the Company's new digital asset treasury strategy focused on the Aethir (ATH) token. The Company announced today that Shawn Matthews, CEO of

    10/14/25 8:00:00 AM ET
    $POAI
    Industrial Specialties
    Health Care

    $AAL
    $ASTI
    $AWIN
    $AZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Exicure Inc.

    SC 13D - EXICURE, INC. (0001698530) (Subject)

    11/29/24 5:51:28 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Faraday Future Intelligent Electric Inc.

    SC 13G/A - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Subject)

    11/14/24 4:56:24 PM ET
    $FFIE
    Auto Manufacturing
    Consumer Discretionary

    SEC Form SC 13G filed by Banzai International Inc.

    SC 13G - Banzai International, Inc. (0001826011) (Subject)

    11/14/24 3:25:52 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    $AAL
    $ASTI
    $AWIN
    $AZ
    Financials

    Live finance-specific insights

    View All

    Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    – Total revenue of $68.7 million in 4Q25 and $172.4 million in FY2025 –  – Revuforj® (revumenib) net revenue of $44.2 million in 4Q25, a 38% increase vs 3Q25, and $124.8 million in FY2025 – – Niktimvo™ (axatilimab-csfr) net revenue of $56.0 million in 4Q25, a 22% increase vs 3Q25, and $151.6 million in FY2025, resulting in Syndax collaboration revenue of $42.4 million in FY2025 – – Completed enrollment in Phase 2 IPF trial of axatilimab; topline data expected in 4Q26 – – Company to host a conference call today at 4:30 p.m. ET – NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer ther

    2/26/26 4:01:00 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its fourth quarter and full year 2025 financial results and provide a business update on Thursday, February 26, 2026. In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Thursday, February 26, 2026. The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company's website. Alternatively, the conference call may be accessed through the

    2/19/26 7:00:00 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ooma Schedules Release of Fourth Quarter & Fiscal 2026 Results

    Ooma, Inc. (NYSE:OOMA), a provider of advanced communications services for businesses and consumers, plans to release its financial results for the fourth quarter and fiscal year ended January 31, 2026 after the market closes on Wednesday, March 4, 2026. The company will host a conference call and live webcast for analysts and investors at 5:00 p.m., Eastern time on March 4, 2026. The news release with the financial results will be accessible from the company's website prior to the conference call. To access the call by phone, please visit https://register-conf.media-server.com/register/BIecc39409caf643709ef5fe469f156982 to register and receive the dial-in details. To avoid delays, Ooma

    2/12/26 4:15:00 PM ET
    $OOMA
    EDP Services
    Technology

    $AAL
    $ASTI
    $AWIN
    $AZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP Chief Operating Officer Seymour David covered exercise/tax liability with 8,350 shares, decreasing direct ownership by 0.73% to 1,135,697 units (SEC Form 4)

    4 - American Airlines Group Inc. (0000006201) (Issuer)

    2/23/26 4:16:31 PM ET
    $AAL
    Air Freight/Delivery Services
    Consumer Discretionary

    SVP Corporate Controller Owens Angela covered exercise/tax liability with 7,808 shares, decreasing direct ownership by 3% to 266,141 units (SEC Form 4)

    4 - American Airlines Group Inc. (0000006201) (Issuer)

    2/23/26 4:16:03 PM ET
    $AAL
    Air Freight/Delivery Services
    Consumer Discretionary

    EVP Chief Financial Officer May Devon E covered exercise/tax liability with 8,350 shares, decreasing direct ownership by 0.81% to 1,018,744 units (SEC Form 4)

    4 - American Airlines Group Inc. (0000006201) (Issuer)

    2/23/26 4:15:32 PM ET
    $AAL
    Air Freight/Delivery Services
    Consumer Discretionary